Cart
sales@molnova.com
AZD6088
CAS No. 1131451-40-5
AZD6088( AZD-6088 | AZD 6088 )
Catalog No. M10458 CAS No. 1131451-40-5
AZD6088 (AZD-6088) is a potent and selective, orally bioavailable partial agonist of the M1 muscarinic receptor, reduces heat hyperalgesia in SNL rats with an EC50 of 46.6 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAZD6088
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZD6088 (AZD-6088) is a potent and selective, orally bioavailable partial agonist of the M1 muscarinic receptor, reduces heat hyperalgesia in SNL rats with an EC50 of 46.6 nM.
-
DescriptionAZD6088 (AZD-6088) is a potent and selective, orally bioavailable partial agonist of the M1 muscarinic receptor, reduces heat hyperalgesia in SNL rats with an EC50 of 46.6 nM.Pain Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsAZD-6088 | AZD 6088
-
PathwayGPCR/G Protein
-
TargetmAChR
-
RecptormAChR
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number1131451-40-5
-
Formula Weight406.571
-
Molecular FormulaC22H38N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)OC(=O)N1CCC(CC1)(C)N2CCC(CC2)N3C4CCCCC4NC3=O
-
Chemical Nameisopropyl 4'-methyl-4-((7aS)-2-oxooctahydro-1H-benzo[d]imidazol-1-yl)-[1,4'-bipiperidine]-1'-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Viberg A, et al. AAPS J. 2012 Dec;14(4):657-63. doi: 10.1208/s12248-012-9380-3.
molnova catalog
related products
-
AZD 9164
A novel highly potent, selective, long acting muscarinic receptor M3 antagonist with pIC50 of 9.8, 10-fold selectivity over M2 (pIC50=9.0).
-
Biperiden
Biperiden (KL 373) is a centrally-acting antiparkinsonian agent that functions as a selective central M1 cholinoreceptors blocker.
-
Batefenterol
A bifunctional M3 mAChR antagonist and β2-adrenoceptor agonist (MABA) with pKi/pEC50 of 8.7/9.6 for hM3/hβ2 respectively.
